Leading European VC believes this is the “Post-It of Surgery”

Gecko BiomedicalGecko has a hot piece of MedTech in its hands: a surgical glue that can stop bleeding from sutured tissues, and in the future could replace stitching altogether.

This technology was initially developed at MIT by a wonder team, but it was in France that it became a commercial project. Paris-based Gecko has the exclusive license for this bio-glue, and was founded by the original Boston team.

Shortly after, it went through its first fundraising and got €8M from French investors specializing in SMEs and healthcare (Omnes Capital, CM-CIC and CapDecisif Management).

Gecko has now raised an additional €22.5M in a series A2 round (A2 being the modest European twin of US series B rounds, perhaps?). There are two new big investors – Bpifrance (a very active investment arm of the French State) and Sofinnova, which is one of our top European Biotech VCs.


About Peter Coffaro 1149 Articles

A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.